Jinren Zhou

1.6k total citations · 1 hit paper
24 papers, 963 citations indexed

About

Jinren Zhou is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Jinren Zhou has authored 24 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Jinren Zhou's work include Liver Disease Diagnosis and Treatment (9 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Jinren Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Jinren Zhou collaborates with scholars based in China, United States and Bangladesh. Jinren Zhou's co-authors include Haoming Zhou, Ling Lü, Xiangyü Li, Yuan Liang, Ji Gao, Qiuyang Chen, Xiaozhang Xu, Bo Zhou, Qing Shao and Qi Wang and has published in prestigious journals such as Oncogene, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Jinren Zhou

23 papers receiving 959 citations

Hit Papers

Tumor metabolite lactate promotes tumorigenesis by modula... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinren Zhou China 15 478 314 267 229 144 24 963
Jack Leslie United Kingdom 17 396 0.8× 174 0.6× 208 0.8× 260 1.1× 184 1.3× 34 1.1k
Guangyi Wang China 20 478 1.0× 144 0.5× 230 0.9× 195 0.9× 234 1.6× 66 997
Dongxian Guan China 14 503 1.1× 154 0.5× 250 0.9× 104 0.5× 255 1.8× 17 891
Saioa Goñi Spain 16 504 1.1× 109 0.3× 171 0.6× 167 0.7× 156 1.1× 28 900
Jian Gu China 18 652 1.4× 216 0.7× 462 1.7× 154 0.7× 128 0.9× 46 1.1k
Bai Ruan China 22 782 1.6× 169 0.5× 567 2.1× 295 1.3× 195 1.4× 33 1.3k
Chengyu Shi China 15 386 0.8× 104 0.3× 215 0.8× 148 0.6× 119 0.8× 26 659
Yaojie Fu United States 21 678 1.4× 302 1.0× 436 1.6× 469 2.0× 372 2.6× 31 1.5k
Mei ElGindi United States 9 193 0.4× 209 0.7× 151 0.6× 324 1.4× 205 1.4× 15 833

Countries citing papers authored by Jinren Zhou

Since Specialization
Citations

This map shows the geographic impact of Jinren Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinren Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinren Zhou more than expected).

Fields of papers citing papers by Jinren Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinren Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinren Zhou. The network helps show where Jinren Zhou may publish in the future.

Co-authorship network of co-authors of Jinren Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jinren Zhou. A scholar is included among the top collaborators of Jinren Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinren Zhou. Jinren Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yilong, Ruoqi Wang, Jinren Zhou, et al.. (2025). Myricetin alleviates high-fat diet-induced atherosclerosis in ApoE−/− mice by regulating bile acid metabolism involved in gut microbiota remodeling. Food & Function. 16(7). 2737–2749. 4 indexed citations
3.
Liang, Yuan, Qingfa Bu, Wenhua You, et al.. (2024). Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167276–167276. 10 indexed citations
4.
Wang, Qi, Qingfa Bu, Zibo Xu, et al.. (2024). Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clinical and Molecular Hepatology. 30(3). 515–538. 11 indexed citations
5.
Liu, Zheng, Hao Wang, Leyong Yuan, et al.. (2024). E2F2 Reprograms Macrophage Function By Modulating Material and Energy Metabolism in the Progression of Metabolic Dysfunction‐Associated Steatohepatitis. Advanced Science. 11(48). e2410880–e2410880. 8 indexed citations
6.
Zhou, Jinren, et al.. (2023). Regulatory T cells (Tregs) in liver fibrosis. Cell Death Discovery. 9(1). 53–53. 49 indexed citations
7.
Wang, Qi, Qingfa Bu, Mu Liu, et al.. (2022). XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. JHEP Reports. 4(11). 100555–100555. 74 indexed citations
8.
Zhou, Jinren, Qing Shao, Yunjie Lu, et al.. (2022). Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients. Frontiers in Oncology. 12. 960066–960066. 16 indexed citations
9.
Gu, Jian, Jinren Zhou, Qiuyang Chen, et al.. (2022). Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Reports. 39(12). 110986–110986. 298 indexed citations breakdown →
10.
Gu, Jian, Qing Shao, Jinren Zhou, Qiuyang Chen, & Ling Lü. (2022). Protocol for in vitro isolation, induction, expansion, and determination of human natural regulatory T cells and induced regulatory T cells. STAR Protocols. 3(4). 101740–101740. 4 indexed citations
11.
Rong, Dawei, Fan Wu, Lu Chen, et al.. (2021). m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Molecular Therapy — Nucleic Acids. 26. 637–648. 77 indexed citations
12.
Gan, Xiaojie, Jiannan Qiu, Ji Gao, et al.. (2021). IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment. Molecular Immunology. 133. 163–172. 16 indexed citations
13.
Deng, Zhenhua, Jinren Zhou, Xiaoxin Mu, et al.. (2021). Regulatory T Cells Improved the Anti-cirrhosis Activity of Human Amniotic Mesenchymal Stem Cell in the Liver by Regulating the TGF-β-Indoleamine 2,3-Dioxygenase Signaling. Frontiers in Cell and Developmental Biology. 9. 737825–737825. 6 indexed citations
14.
Wang, Peng, Ming Ni, Yizhu Tian, et al.. (2021). Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling. iScience. 24(5). 102427–102427. 26 indexed citations
15.
Qiu, Jiannan, Song Wei, Mu Liu, et al.. (2021). Lycopene alleviates hepatic ischemia reperfusion injury via the Nrf2/HO-1 pathway mediated NLRP3 inflammasome inhibition in Kupffer cells. Annals of Translational Medicine. 9(8). 631–631. 31 indexed citations
16.
Shao, Qing, Jian Gu, Jinren Zhou, et al.. (2021). Tissue Tregs and Maintenance of Tissue Homeostasis. Frontiers in Cell and Developmental Biology. 9. 717903–717903. 35 indexed citations
17.
Zhang, Yigang, Wenhua You, Xiangyü Li, et al.. (2021). Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment. Annals of Translational Medicine. 9(10). 889–889. 15 indexed citations
18.
Shi, Yong, Wantong Su, Lei Zhang, et al.. (2021). TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation. Frontiers in Immunology. 11. 609060–609060. 129 indexed citations
19.
Gan, Xiaojie, Rongsheng Zhang, Jian Gu, et al.. (2020). Acidic Microenvironment Regulates the Severity of Hepatic Ischemia/Reperfusion Injury by Modulating the Generation and Function of Tregs via the PI3K-mTOR Pathway. Frontiers in Immunology. 10. 2945–2945. 27 indexed citations
20.
Li, Jinyang, Ji Gao, Haoming Zhou, et al.. (2020). Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19+CD24hiCD27+ Breg Cells. Frontiers in Immunology. 11. 603288–603288. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026